SOPHiA GENETICS SA - Ordinary Shares (SOPH)
SOPH moved a median of 0.00% 30 minutes after news, and +0.10% by the close. How SOPH actually reacts to news — the realized, point-in-time move the market made, measured across 573 labeled events over the last three years with zero look-ahead.
SOPH’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 35% | 533 |
| 30-min | 0.00% | 50% | 561 |
| 60-min | +0.00% | 51% | 565 |
| to close | +0.10% | 50% | 568 |
| Middle 50% of SOPH reactions | -1.05% to +1.04% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 573 |
Half of all SOPHiA GENETICS SA - Ordinary Shares news events land between -1.05% and +1.04% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How SOPH reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 14 | +0.94% | 86% | +4.27% |
| Rating reiterations | 21 | -1.10% | 24% | -0.46% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how SOPH ranks against every other measured name →
That’s how SOPH usually reacts — get an email when it moves on news →Email me when SOPH moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SOPH's baseline. Nothing else.
Recent SOPH events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026 | Press release | PR Newswire | -0.45% | — | |
| SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology | Press release | Canada Newswire | -1.26% | +2.10% | |
| Form 6-K SOPHiA GENETICS SA For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +0.17% | +13.06% | |
| SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies | Press release | Canada Newswire | +0.17% | +13.06% | |
| SOPHiA GENETICS Reports Second Quarter 2026 Results | Press release | PR Newswire | +0.17% | +13.06% | |
| SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026 | Press release | PR Newswire | +0.46% | +0.00% | |
| Form 6-K SOPHiA GENETICS SA For: Jun 18 | SEC filing · Form 6-K | SEC EDGAR | +3.30% | +0.76% | |
| Form 6-K SOPHiA GENETICS SA For: Jun 22 | SEC filing · Form 6-K | SEC EDGAR | +3.30% | +0.76% | |
| SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting | Press release | PR Newswire | +3.30% | +0.76% | |
| SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares | Press release | PR Newswire | +3.30% | +0.76% | |
| SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares | Press release | PR Newswire | +1.80% | +4.80% | |
| SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares | Press release | PR Newswire | +1.80% | +4.80% | |
| SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting | Press release | Canada Newswire | -2.41% | -3.33% | |
| Form 6-K SOPHiA GENETICS SA For: Jun 04 | SEC filing · Form 6-K | SEC EDGAR | +1.03% | +2.48% | |
| SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center | Press release | PR Newswire | +1.03% | +2.48% | |
| Form 6-K SOPHiA GENETICS SA For: May 19 | SEC filing · Form 6-K | SEC EDGAR | -1.17% | -0.64% | |
| Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K. | Press release | Canada Newswire | -1.05% | -5.45% | |
| Form 6-K SOPHiA GENETICS SA For: May 07 | SEC filing · Form 6-K | SEC EDGAR | -0.18% | -4.98% | |
| Form 6-K SOPHiA GENETICS SA For: Mar 31 | SEC filing · Form 6-K | SEC EDGAR | +1.42% | +2.84% | |
| SOPHiA GENETICS Reports First Quarter 2026 Results | Press release | PR Newswire | +1.42% | +2.84% | |
| SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026 | Press release | PR Newswire | -0.29% | -1.73% | |
| Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026 | Press release | Canada Newswire | -1.95% | +0.00% | |
| Form EFFECT SOPHiA GENETICS SA | SEC filing · Form EFFECT | SEC EDGAR | +2.25% | +2.53% | |
| Form 20-F SOPHiA GENETICS SA For: Dec 31 | SEC filing · Form 20-F | SEC EDGAR | -0.22% | -11.06% | |
| Form 6-K SOPHiA GENETICS SA For: Dec 31 | SEC filing · Form 6-K | SEC EDGAR | -0.22% | -11.06% | |
| Form F-3 SOPHiA GENETICS SA | SEC filing · Form F-3 | SEC EDGAR | -2.67% | +2.55% | |
| SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results | Press release | PR Newswire | -0.22% | -11.06% | |
| SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference | Press release | PR Newswire | +2.08% | +0.66% | |
| SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 | Press release | PR Newswire | +0.85% | +1.28% | |
| SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems | Press release | PR Newswire | +2.17% | -1.44% | |
| Form 6-K SOPHiA GENETICS SA For: Jan 28 | SEC filing · Form 6-K | SEC EDGAR | -0.94% | -2.45% | |
| Form 6-K SOPHiA GENETICS SA For: Dec 31 | SEC filing · Form 6-K | SEC EDGAR | -6.00% | -6.36% | |
| Form 6-K SOPHiA GENETICS SA For: Jan 12 | SEC filing · Form 6-K | SEC EDGAR | -0.98% | +0.59% | |
| SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan | Press release | PR Newswire | -6.00% | -6.36% | |
| SOPHiA GENETICS verstrekt voorlopige financiële resultaten voor het vierde kwartaal en het volledige jaar 2025, geeft richtsnoeren voor 2026 en kondigt overgangsplan voor de directie aan | Press release | PR Newswire | -6.00% | -6.36% | |
| SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology | Press release | PR Newswire | -1.03% | +3.09% | |
| Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025 | Press release | PR Newswire | -1.53% | +1.09% | |
| SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine | Press release | PR Newswire | -1.53% | +1.09% | |
| SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine | Press release | PR Newswire | -1.53% | +1.09% | |
| Form 6-K SOPHiA GENETICS SA For: Sep 30 | SEC filing · Form 6-K | SEC EDGAR | +1.62% | -2.90% | |
| SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance | Press release | PR Newswire | +1.62% | -2.90% | |
| SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 | Press release | PR Newswire | +0.21% | +0.48% | |
| A.D.A.M. Innovations en SOPHiA GENETICS werken samen om vloeibare biopsietests en begeleidende diagnostiek voor precisieloncologie te bevorderen in Japan | Press release | PR Newswire | — | -0.67% | |
| A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan | Press release | PR Newswire | +2.65% | +0.00% | |
| SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology | Press release | PR Newswire | +1.00% | -0.89% | |
| Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy | Press release | Canada Newswire | -1.29% | +2.33% | |
| SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer | Press release | Canada Newswire | +1.24% | +21.30% | |
| SOPHiA GENETICS en Jessa Ziekenhuis kondigen samenwerking aan op het gebied van precisieoncologie tijdens het European Congress of Pathology | Press release | PR Newswire | +0.01% | -0.88% | |
| SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology | Press release | PR Newswire | -1.18% | -4.42% | |
| Form EFFECT SOPHiA GENETICS SA | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | +1.45% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SOPH section they belong to.
Where else SOPH is measured.
SOPH earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is SOPHiA GENETICS SA - Ordinary Shares's median reaction calculated?
Every labeled SOPH news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 573 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 50% of SOPH's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does SOPH's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.